Post-Essential Thrombocythemia (ET) MF
Showing 1 - 25 of >10,000
Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)
Not yet recruiting
- Myelofibrosis (PMF)
- +2 more
-
New York, New YorkRuttenberg Treatment Center
Apr 18, 2023
Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)
Recruiting
- Primary Myelofibrosis
- +4 more
-
New York, New YorkRuttenberg Treatment Center
Jul 18, 2022
Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston
Completed
- Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Houston, TexasM D Anderson Cancer Center
May 27, 2022
Myelofibrosis Trial in Canton (Jaktinib Hydrochloride Tablet)
Recruiting
- Myelofibrosis
- Jaktinib Hydrochloride Tablet
-
Canton, OhioSite 01
Aug 18, 2022
Primary Myelofibrosis, Polycythemia Vera, Post-Essential Thrombocythemia Myelofibrosis Trial in Worldwide (RO7490677,
Primary Myelofibrosis (PMF), Post-polycythemia Vera (Post-PV) Myelofibrosis, Postessential Thrombocythemia (Post-ET)
Completed
- Primary Myelofibrosis (PMF)
- +2 more
-
Phoenix, Arizona
- +12 more
Jan 12, 2021
Assess the Safety of Fedratinib in Korean Myelofibrosis
Recruiting
- Primary Myelofibrosis
- +2 more
-
Seoul, Korea, Republic ofBristol-Myers Squibb YH
Oct 3, 2023
Essential Thrombocythemia Trial (Ropeginterferon alfa-2b-njft (P1101))
Not yet recruiting
- Essential Thrombocythemia
- Ropeginterferon alfa-2b-njft (P1101)
- (no location specified)
Jul 28, 2022
Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,
Recruiting
- Primary Myelofibrosis
- +2 more
- NS-018
- Best Available Therapy
-
Worcester, Massachusetts
- +16 more
Oct 31, 2022
Primary Myelofibrosis (PMF), Post-Polycythemia Vera MF (Post-PV-MF), Post-Essential Thrombocythemia MF (Post-ET-MF) Trial in
Recruiting
- Primary Myelofibrosis (PMF)
- +2 more
- KRT-232
- Best Available Therapy (BAT)
-
Birmingham, Alabama
- +155 more
Aug 12, 2022
The Role of Circ0014614 in the Formation and Development of ET
Recruiting
- Primary Thrombocytosis
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Jun 18, 2023
Idiopathic Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis, Post Polycythemia-Vera Myelofibrosis Trial in Worldwide
Completed
- Idiopathic Myelofibrosis
- +2 more
-
Paris, France
- +9 more
Jun 22, 2021
Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong
Recruiting
- Myeloproliferative Neoplasm
- +7 more
-
Hong Kong, Hong KongDepartment of Medicine, Queen Mary Hospital
May 21, 2023